CLDX Celldex Therapeutics, Inc.Stock Price & Overview
$40.25
Charts
Quant Ranking
CLDX Analysis
CLDX News
Latest Headlines
Ratings Summary
People Also Follow
Similar to CLDX
ETFs Holding CLDX
CLDX Company Profile
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company’s clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
CLDX Revenue
CLDX Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
CLDX Ownership
CLDX Peers
Risk
Technicals
CLDX Transcripts
Investor Presentations
CLDX SEC Filings
Press Releases
CLDX Income Statement
CLDX Balance Sheet
CLDX Cash Flow Statement
CLDX Long Term Solvency
Discover More
You may be interested in: